These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34192127)

  • 21. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study.
    Wang J; Zhu L; Xue L; Liu L; Yan X; Yan X; Huang S; Zhang B; Xu T; Li C; Ji F; Ming F; Zhao Y; Cheng J; Shao H; Chen K; Zhao XA; Sang D; Zhao H; Guan X; Chen X; Chen Y; Liu J; Huang R; Zhu C; Wu C
    J Med Virol; 2021 Jun; 93(6):3305-3311. PubMed ID: 33174624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.
    Chaibi S; Boussier J; Hajj WE; Abitbol Y; Taieb S; Horaist C; Jouannaud V; Wang P; Piquet J; Maurer C; Lahmek P; Nahon S
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101556. PubMed ID: 33139241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
    Tripon S; Bilbault P; Fabacher T; Lefebvre N; Lescuyer S; Andres E; Schmitt E; Garnier-KepKA S; Borgne PL; Muller J; Merdji H; Chaffraix F; Mutter D; Baumert TF; Meziani F; Doffoel M
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101894. PubMed ID: 35227956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study.
    Riou M; Marcot C; Canuet M; Renaud-Picard B; Chatron E; Porzio M; Dégot T; Hirschi S; Metz-Favre C; Kassegne L; Ederle C; Khayath N; Labani A; Leyendecker P; De Blay F; Kessler R;
    Respir Med Res; 2021 May; 79():100801. PubMed ID: 33259989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
    Gu X; Li X; An X; Yang S; Wu S; Yang X; Wang H
    J Clin Lab Anal; 2020 Jul; 34(7):e23391. PubMed ID: 32488888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis.
    Kovalic AJ; Satapathy SK; Thuluvath PJ
    Hepatol Int; 2020 Sep; 14(5):612-620. PubMed ID: 32725453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sources and clinical significance of aspartate aminotransferase increases in COVID-19.
    Aloisio E; Colombo G; Arrigo C; Dolci A; Panteghini M
    Clin Chim Acta; 2021 Nov; 522():88-95. PubMed ID: 34411557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and mechanism of liver injury in patients with mild or moderate coronavirus disease 2019.
    Gomi K; Ito T; Yamaguchi F; Kamio Y; Sato Y; Mori H; Endo K; Abe T; Sakakura S; Kobayashi K; Shimada K; Noda J; Hibiki T; Ohta S; Sagara H; Tanaka A; Jinno M; Yamawaki M; Nishimoto F; Inoue K; Nagahama M
    JGH Open; 2021 Aug; 5(8):888-895. PubMed ID: 34386596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.
    Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH
    Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver injury on admission linked to worse outcomes in COVID-19: an analysis of 14,138 patients.
    Chela HK; Tallon EM; Baskett W; Gangu K; Tahan V; Shyu CR; Daglilar E
    Transl Gastroenterol Hepatol; 2023; 8():4. PubMed ID: 36704655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience.
    Hashemi N; Viveiros K; Redd WD; Zhou JC; McCarty TR; Bazarbashi AN; Hathorn KE; Wong D; Njie C; Shen L; Chan WW
    Liver Int; 2020 Oct; 40(10):2515-2521. PubMed ID: 32585065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality.
    Satapathy SK; Kuntzen C; Qiu H; Jiang Y; Bodenheimer HC; Roth NC; Lee TP; Hirsch JS; Trindade AJ; Bernstein DE;
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e320-e328. PubMed ID: 33560687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease.
    Mak LY; Chung MSH; Li X; Lai FTT; Wan EYF; Chui CSL; Cheng FWT; Chan EWY; Cheung CL; Au ICH; Xiong X; Seto WK; Yuen MF; Wong CKH; Wong ICK
    World J Hepatol; 2024 Feb; 16(2):211-228. PubMed ID: 38495273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study.
    Madian A; Eliwa A; Abdalla H; Aly HAA
    World J Hepatol; 2021 Aug; 13(8):939-948. PubMed ID: 34552700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.
    Turgutalp K; Ozturk S; Arici M; Eren N; Gorgulu N; Islam M; Uzun S; Sakaci T; Aydin Z; Sengul E; Demirelli B; Ayar Y; Altiparmak MR; Sipahi S; Mentes IB; Ozler TE; Oguz EG; Huddam B; Hur E; Kazancioglu R; Gungor O; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Odabas AR; Ates K
    BMC Nephrol; 2021 Jan; 22(1):29. PubMed ID: 33446135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
    Liao FL; Peng DH; Chen W; Hu HN; Tang P; Liu YY; Luo Y; Yao T
    J Med Virol; 2021 Apr; 93(4):2365-2373. PubMed ID: 33314141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.